MarketCap
Facebook
X
Telegram
Evelo Biosciences EV/EBITDA Ratio | EVLO
Annual EV/EBITDA Ratio Evelo Biosciences
| 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| -0.456 | -2.3 | -7.61 | -1.67 | -2.25 | 0.878 | 0.219 | - | - | - | - | - |
Annual performance
Select metrics to display
All numbers in USD currency
Indicator range from annual reports
| Maximum | Minimum | Average |
|---|---|---|
| 0.878 | -7.61 | -1.88 |
EV/EBITDA Ratio of other stocks in the Biotechnology industry
| Issuer | EV/EBITDA Ratio | Price | % 24h | Market Cap | Country | |
|---|---|---|---|---|---|---|
 |
Seer
SEER
|
0.144 | $ 1.62 | -3.57 % | $ 89.7 M |  USA |
 |
Gracell Biotechnologies
GRCL
|
2.07 | - | - | $ 3.37 B |  China |
 |
Shattuck Labs
STTK
|
-6.35 | $ 4.86 | -2.71 % | $ 338 M | USA |
 |
Silence Therapeutics plc
SLN
|
-48.1 | $ 19.78 | 0.15 % | $ 2.8 B |  Britain |
 |
Stoke Therapeutics
STOK
|
-106 | $ 27.16 | -1.98 % | $ 1.61 B | USA |
 |
Sutro Biopharma
STRO
|
-2.84 | $ 10.08 | -5.0 % | $ 85.7 M | USA |
 |
Soligenix
SNGX
|
-0.18 | $ 0.32 | -6.35 % | $ 1.66 M | USA |
 |
Teva Pharmaceutical Industries Limited
TEVA
|
22.4 | $ 42.54 | -1.0 % | $ 48.7 B |  Israel |
 |
China SXT Pharmaceuticals
SXTC
|
3.12 | $ 2.99 | -3.55 % | $ 2.03 M | China |
 |
Spruce Biosciences
SPRB
|
-0.252 | $ 46.36 | -6.04 % | $ 35.5 M | USA |
 |
Takeda Pharmaceutical Company Limited
TAK
|
20.3 | $ 20.9 | -0.9 % | $ 33 B |  Japan |
 |
Supernus Pharmaceuticals
SUPN
|
115 | $ 28.77 | 4.15 % | $ 1.62 B | USA |
 |
Galapagos NV
GLPG
|
5.67 | - | - | $ 1.83 B |  Belgium |
 |
Savara
SVRA
|
-9.6 | $ 4.92 | -2.57 % | $ 1.09 B | USA |
 |
Teligent, Inc.
TLGT
|
2.8 | - | -13.85 % | $ 16.1 M | USA |
 |
Viela Bio, Inc.
VIE
|
-1.96 | - | - | $ 2.91 B | USA |
 |
TG Therapeutics
TGTX
|
37.9 | $ 64.27 | 1.4 % | $ 9.28 B | USA |
 |
Aphria Inc.
APHA
|
-117 | - | -0.45 % | $ 4.87 B |  Canada |
 |
Aerpio Pharmaceuticals, Inc.
ARPO
|
-3.41 | - | -0.90 % | $ 104 M | USA |
 |
Chiasma, Inc.
CHMA
|
-2.73 | - | -6.00 % | $ 238 M | USA |
 |
Trevi Therapeutics
TRVI
|
-30.5 | $ 14.92 | -2.55 % | $ 2.01 B | USA |
 |
Adamas Pharmaceuticals, Inc.
ADMS
|
-5.12 | - | - | $ 376 M | USA |
 |
Cellect Biotechnology Ltd.
APOP
|
27.1 | - | 0.38 % | $ 12.9 M | Israel |
 |
AzurRx BioPharma, Inc.
AZRX
|
-0.000002 | - | 2.07 % | $ 34.4 M | USA |
 |
Cerecor Inc.
CERC
|
-4.65 | - | -1.68 % | $ 283 M | USA |
 |
Constellation Pharmaceuticals, Inc.
CNST
|
-11.6 | - | - | $ 1.63 B | USA |
 |
Auris Medical Holding Ltd.
EARS
|
0.463 | - | -1.77 % | $ 39.2 M |  Bermuda |
 |
Dicerna Pharmaceuticals, Inc.
DRNA
|
-14.4 | - | 0.34 % | $ 2.98 B | USA |
 |
ERYTECH Pharma S.A.
ERYP
|
5.22 | - | 1.3 % | $ 27.7 M |  France |
 |
GW Pharmaceuticals plc
GWPH
|
-110 | - | - | $ 6.81 B | Britain |
 |
Kadmon Holdings, Inc.
KDMN
|
-7.37 | - | - | $ 1.7 B | USA |
 |
Liminal BioSciences
LMNL
|
-0.811 | - | - | $ 256 M | Canada |
 |
argenx SE
ARGX
|
38.2 | $ 972.42 | 1.05 % | $ 59.6 B |  Niderland |
|
XBiotech
XBIT
|
0.841 | $ 1.97 | 3.2 % | $ 60.1 M | USA |
 |
Neos Therapeutics, Inc.
NEOS
|
-17.5 | - | -2.54 % | $ 57.2 M | USA |
 |
Odonate Therapeutics, Inc.
ODT
|
-4.74 | - | -3.18 % | $ 58.5 M | USA |
 |
Orphazyme A/S
ORPH
|
0.718 | - | -2.25 % | $ 31.3 M |  Danmark |
 |
Osmotica Pharmaceuticals plc
OSMT
|
16.1 | - | -10.74 % | $ 89.9 M | USA |
 |
Pandion Therapeutics, Inc.
PAND
|
-11.2 | - | - | $ 1.77 B | USA |
 |
Xenetic Biosciences
XBIO
|
0.897 | $ 1.76 | -2.09 % | $ 2.99 M | USA |
 |
Viridian Therapeutics
VRDN
|
-8.14 | $ 30.86 | 2.22 % | $ 3.14 B | USA |
 |
Translate Bio, Inc.
TBIO
|
350 | - | - | $ 2.81 B | USA |
 |
Trillium Therapeutics Inc.
TRIL
|
-14 | - | - | $ 1.94 B | Canada |
 |
Urovant Sciences Ltd.
UROV
|
-1.91 K | - | - | $ 532 M | Britain |
 |
Acceleron Pharma Inc.
XLRN
|
-47 | - | - | $ 10.9 B | USA |
 |
Zealand Pharma A/S
ZEAL
|
-0.823 | - | 0.52 % | $ 821 M | Danmark |
 |
Zogenix, Inc.
ZGNX
|
-4.47 | - | -4.97 % | $ 664 M | USA |
|
Yunhong International
ZGYH
|
44 | - | 0.10 % | $ 92.2 M | China |
 |
ZIOPHARM Oncology, Inc.
ZIOP
|
-8.58 | - | -7.58 % | $ 264 M | USA |
 |
Xenon Pharmaceuticals
XENE
|
-6.03 | $ 41.4 | 2.35 % | $ 3.28 B | Canada |